Specialized Care for Ulcerative Colitis in Edgewater MD

At Nasseri Clinic of Arthritic and Rheumatic Diseases, our expertise extends to the management of complex immune-mediated conditions, including ulcerative colitis—a chronic inflammatory bowel disease with significant impact on daily life. Our infusion therapy services are tailored to help patients achieve better disease control, reduce inflammation, and improve quality of life.
 
Ulcerative colitis is driven by abnormal immune system activity, which is also a hallmark of many rheumatic and arthritic diseases. Our team of specialists has extensive experience with biologic medications and immunomodulatory therapies that target specific pathways in the immune system. Medications such as infliximab and vedolizumab are administered via infusion in our clinic, offering a targeted approach for patients who may not have responded well to oral treatments.
 
Clinical evidence demonstrates that biologic infusions can induce and maintain remission, decrease the frequency of flare-ups, and help prevent complications associated with ulcerative colitis. At Nasseri Clinic, we understand that every patient’s disease journey is unique. Our physicians create individualized treatment plans, carefully considering each patient’s medical history, disease severity, and previous therapies.
 
Ongoing monitoring is a cornerstone of our approach—our medical team tracks your progress, evaluates therapy effectiveness, and makes adjustments to ensure optimal outcomes. We prioritize open communication and patient education, empowering you to make informed decisions about your care.

It’s important to recognize that while infusion therapy offers many patients a path to long-term remission, individual responses can vary. Some may achieve lasting control of their symptoms, while others might need to explore alternative or additional therapies. Regular follow-up at our clinic ensures you receive the most appropriate and up-to-date care.

At Nasseri Clinic of Arthritic and Rheumatic Diseases, we take a comprehensive, patient-centered approach to choosing between injection and infusion therapies for individuals with arthritis, autoimmune, and other rheumatic conditions. Our process is grounded in the latest clinical guidelines and extensive experience treating complex diseases such as rheumatoid arthritis, psoriatic arthritis, lupus, ankylosing spondylitis, and vasculitis.
 
The decision begins with a thorough evaluation of the patient’s medical history, diagnosis, disease severity, and previous responses to medications. For example, patients with severe rheumatoid arthritis flares or systemic lupus erythematosus may benefit from the controlled, rapid administration of intravenous infusions—especially when biologic medications or immunosuppressants are required. Conversely, patients managing milder forms of osteoarthritis or those with localized joint inflammation may achieve excellent results with periodic injection therapies, such as corticosteroid or hyaluronic acid injections directly into affected joints.
 
Our expert rheumatology team also considers the specific medications indicated for each condition. Some advanced therapies—like certain biologic disease-modifying antirheumatic drugs (DMARDs)—are only available as infusions, while others offer both injectable and infusion options. We evaluate the safety, effectiveness, and pharmacokinetic profiles of these drugs to ensure the chosen delivery method matches each patient’s unique disease characteristics.

Patient-specific factors are always central to our decision-making. We assess each individual’s tolerance for intravenous access, ability or preference for self-injection at home, and how various treatment options fit with their lifestyle, work schedule, or travel requirements. Our team discusses potential side effects, allergic risks, requirements for monitoring, and any necessary accommodations. Additionally, we review insurance coverage and treatment affordability to ensure accessibility and continuity of care.
 
At Nasseri Clinic, treatment decisions are always collaborative. We engage patients in open discussions about the risks, benefits, and practical considerations of both injection and infusion therapies. By personalizing every treatment plan, we aim to optimize outcomes, improve quality of life, and empower our patients to take an active role in their care.

After you complete your initial infusion or injection treatment for ulcerative colitis, ongoing follow-up care and maintenance therapy become critical steps in your long-term health journey. At Nasseri Clinic of Arthritic and Rheumatic Diseases, our experienced team provides comprehensive care to help you maintain remission, closely monitor for potential side effects, and address any disease progression.
 
Our rheumatology specialists will schedule regular follow-up appointments to carefully assess your response to therapy, review any new symptoms, and perform necessary laboratory tests. These may include blood work and, when appropriate, stool studies to monitor for medication side effects and to detect early signs of inflammation. Depending on your individualized treatment plan, your provider may also recommend imaging studies or endoscopic evaluations to ensure your colon remains healthy.
 
Maintenance therapy is highly individualized and may involve continued use of the same medications that were effective during your initial treatment—often at adjusted intervals or dosages. For example, if you received a biologic infusion or injection, you may continue these treatments every few weeks or months, as advised by your Nasseri Clinic provider. In some cases, oral medications such as aminosalicylates, immunomodulators, or other agents may be added or substituted to help maintain long-term disease control.
 
Patient education is a central part of our approach. Our team will teach you how to recognize early symptoms of flare-ups and potential medication side effects. We provide detailed guidance on when to seek medical attention and offer information on lifestyle modifications, dietary recommendations, and the importance of adhering to your medication schedule. For patients receiving immunosuppressive therapy, we also review vaccination status and infection risk as part of your routine care.

Dr. Nasser Nasseri and his team take a proactive, patient-centered approach to managing ulcerative colitis. They combine the latest medical advancements with compassionate care to create a tailored treatment plan for each patient. After a thorough evaluation, the team may recommend a combination of medications, lifestyle adjustments, and regular monitoring to help manage symptoms and effectively address flare-ups. Dr. Nasseri’s comprehensive approach focuses on long-term symptom management, with the goal of improving your quality of life and achieving lasting remission.

At Nasseri Clinic of Arthritic and Rheumatic Diseases, our goal is to partner with you for optimal long-term management of ulcerative colitis. Through regular monitoring, personalized maintenance therapy, and open communication, we strive to help you achieve the best possible disease control and quality of life. For more information, contact us or book an appointment online. We are conveniently located at 3168 Braverton St., Suite 330B, Edgewater, MD 21037. We serve patients from Edgewater MD, Riva MD, Davidsonville MD, Annapolis MD, and surrounding areas.